Reference : Validation of manufacturing process of Diltiazem HCl tablets by NIR spectrophotometry (N...
Scientific journals : Article
Human health sciences : Pharmacy, pharmacology & toxicology
http://hdl.handle.net/2268/1642
Validation of manufacturing process of Diltiazem HCl tablets by NIR spectrophotometry (NIRS)
English
Bodson, Cédric [ > > ]
Rozet, Eric mailto [Université de Liège - ULg > > Chimie analytique >]
Ziemons, Eric mailto [Université de Liège - ULg > > Chimie analytique >]
Evrard, Brigitte mailto [Université de Liège - ULg > Département de pharmacie > Pharmacie galénique >]
Hubert, Philippe mailto [Université de Liège - ULg > > Chimie analytique >]
Delattre, Luc mailto [Université de Liège - ULg > Département de pharmacie > Département de pharmacie >]
18-Oct-2007
Journal of Pharmaceutical & Biomedical Analysis
Elsevier Science Ltd
45
2
356-361
Yes (verified by ORBi)
International
0731-7085
Amsterdam
The Netherlands
[en] NIR spectroscopy ; Validation ; Manufacturing process ; Tablet assay ; PAT
[en] The goal of this study was to apply the Process Analytical Technology FDA's initiative in pharmaceutical tablets manufacturing. Near Infrared Spectrophotometry (NIRS) was used as a non-destructive, very fast technique requiring no sample preparation. Direct compression powder blends containing Diltiazem HCl as a model drug were pressed into tablets for the calibration and the validation steps. First, a partial least squares model was built to calibrate the NIR spectrometer. Then, this model was validated and compared with a validated UV spectrophotometry reference method. For this comparison, the Bland and Altman's statistical method was applied. The manufacturing process was validated by producing three batches at three different concentration levels. The NIR analysis of these batches was performed during 3 days. This study shows that NIRS can be used to validate the whole manufacturing process and not only as an analytical method for tablets assay. NIRS is an interesting tool to show possible variations during the manufacturing process which could lead the finished product to fall outside of specifications.
C.I.R.M.
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/1642
10.1016/j.jpba.2007.05.015

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
JPBA_CBodson_2007.pdfPublisher postprint670.32 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.